Medicare Enrolled
Dr. Rokhsana Zaheen, MD
Family Medicine · Reedley, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Zaheen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zaheen?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zaheen
Dr. Rokhsana Zaheen is a family medicine specialist in Reedley, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Zaheen performed 2,450 Medicare services across 1,510 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zaheen received a total of $11,084 from 49 pharmaceutical and/or device companies across 696 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zaheen is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 8% volume in CA
$11,084 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,450
Medicare services
Top 8% in CA for family medicine
1,510
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~122 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
662 | $87 | $405 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
351 | $50 | $134 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
192 | $4 | $15 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
139 | $32 | $69 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
130 | $72 | $183 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
104 | $82 | $263 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
94 | $66 | $285 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
88 | $135 | $413 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
84 | $71 | $286 |
| Annual depression screening | 82 | $20 | $59 |
| Respiratory virus detection test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus and influenza viruses. |
74 | $51 | $169 |
| COVID-19 vaccine administration Administration of a single dose of the coronavirus vaccine. |
72 | $43 | $120 |
| COVID-19 vaccine (Moderna bivalent) An intramuscular injection of the SARS-CoV-2 vaccine containing 50 micrograms in a 0.5 mL dose. |
68 | $143 | $438 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
65 | $41 | $230 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
60 | $1 | $13 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
44 | $3 | $16 |
| Adm sarscv2 bvl 50mcg/.5ml a | 42 | $43 | $71 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
28 | $11 | $69 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
16 | $57 | $219 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
16 | $6 | $45 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
15 | $172 | $523 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
13 | $11 | $76 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
11 | $32 | $45 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,084
Total received (2018-2024)
Avg $1,583/year across 7 years
Top 4% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
696
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,067 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$17 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$923
2023
$919
2022
$1,230
2021
$2,210
2020
$1,351
2019
$2,235
2018
$2,217
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$163
AstraZeneca Pharmaceuticals LP
$162
PFIZER INC.
$151
GlaxoSmithKline, LLC.
$97
Lilly USA, LLC
$83
Dexcom, Inc.
$58
Boehringer Ingelheim Pharmaceuticals, Inc.
$50
Ardelyx, Inc.
$44
Dynavax Technologies Corporation
$28
SHIELD THERAPEUTICS INC
$23
Regeneron Healthcare Solutions, Inc.
$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$21
Xeris Pharmaceuticals, Inc.
$20
Top 3 companies account for 51.7% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,275
AstraZeneca Pharmaceuticals LP
$1,054
Novo Nordisk Inc
$969
Kowa Pharmaceuticals America, Inc.
$725
Lilly USA, LLC
$583
Amgen Inc.
$567
Abbott Laboratories
$518
PFIZER INC.
$506
Janssen Pharmaceuticals, Inc
$472
Boehringer Ingelheim Pharmaceuticals, Inc.
$443
Biohaven Pharmaceuticals, Inc.
$404
SANOFI-AVENTIS U.S. LLC
$377
Teva Pharmaceuticals USA, Inc.
$308
AbbVie Inc.
$273
Takeda Pharmaceuticals U.S.A., Inc.
$269
Merck Sharp & Dohme Corporation
$222
ABBVIE INC.
$184
Novartis Pharmaceuticals Corporation
$181
Nevro Corp.
$161
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$161
Ironwood Pharmaceuticals, Inc
$159
Biohaven Pharmaceutical Holding Company Ltd.
$152
Amarin Pharma Inc.
$148
Dexcom, Inc.
$127
Philips Electronics North America Corporation
$93
Genentech USA, Inc.
$79
ARBOR PHARMACEUTICALS, INC.
$77
SANOFI PASTEUR INC.
$50
Shield Therapeutics Inc
$48
Ardelyx, Inc.
$44
Allergan Inc.
$41
IRONWOOD PHARMACEUTICALS, INC
$35
Arbor Pharmaceuticals, Inc.
$33
Hologic, LLC
$33
Dynavax Technologies Corporation
$28
Allergan, Inc.
$28
MannKind Corporation
$25
SHIELD THERAPEUTICS INC
$23
Exact Sciences Corporation
$23
Agile Therapeutics, Inc.
$23
Sanofi Pasteur Inc.
$21
Regeneron Healthcare Solutions, Inc.
$21
Xeris Pharmaceuticals, Inc.
$20
AbbVie, Inc.
$18
Horizon Therapeutics plc
$18
E.R. Squibb & Sons, L.L.C.
$18
Nalpropion Pharmaceuticals, Inc.
$17
Bayer Healthcare Pharmaceuticals Inc.
$16
Shire North American Group Inc
$13
Top 3 companies account for 29.8% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AFREZZA · AIRSUPRA · AJOVY · ANORO · Aimovig · AirDuo Digihaler · Amitiza · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · CHANTIX · COMIRNATY · CONTRAVE · Cologuard Collection Kit · Creon · DUPIXENT · DUZALLO · Dexcom G6 Transmitter · ELAPRASE · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbi · Edarbyclor · FARXIGA · FASENRA · FLUBLOK QUADRIVALENT · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · HUMALOG · Health&WellnessUndiv · Heplisav-B · Horizant · IBSRELA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · LINZESS · LYRICA · Linzess · Livalo · MOUNJARO · MYFEMBREE · NURTEC ODT · Otezla · Ozempic · PAXLOVID · PREVNAR 20 · Prolia · QULIPTA · RECORLEV · RYBELSUS · Repatha · Respiratoriy Care Undiv · Rybelsus · SEGLENTIS · SHINGRIX · SIVEXTRO · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Saxenda · Senza · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TV · Tresiba · Trintellix · Twirla · UBRELVY · VIBERZI · Vascepa · Victoza · Vyvanse · Wegovy · Wellcentive Undiv · XARELTO · XIFAXAN · Xofluza · inCourage · thinprep
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
383
Per 100K population
37.8
County median income
$71,434
Nearest hospital
ADVENTIST HEALTH REEDLEY
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Zaheen is a clinical cardiology specialist, with above-average Medicare volume (top 8% in CA), with low-engagement industry engagement in the top 4% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Zaheen experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Zaheen performed 662 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zaheen receive payments from pharmaceutical companies?
Yes. Dr. Zaheen received a total of $11,084 from 49 companies across 696 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zaheen's costs compare to other family medicine physicians in Reedley?
Dr. Zaheen's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zaheen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Reedley
Browse family medicine physicians in Reedley ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology